NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers detail new studies and findings in the area of breast cancer



September 22nd, 2005

Breast cancer data are the focus of recent research from the United States.

Study 1: In a recent study, barriers to minority participation in breast cancer prevention trials were identified.

"Breast carcinoma prevention trials must recruit large cohorts of women who have an above-average risk of developing breast carcinoma," according to researchers from Columbia University in New York. "Recruitment for the Study of Tamoxifen and Raloxifene (STAR) trial required volunteers to complete a risk assessment questionnaire form (RAF)."

"Women whose estimated risk of developing breast carcinoma in the next 5 years was {{>=}}1.67% based...


Source: Women's Health Weekly (2005-09-22)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login